ArticleTrials2022

Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects of magnesium citrate supplementation and phosphate-binding therapy on arterial stiffness in moderate chronic kidney disease.

Emma A Vermeulen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.